These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 12325061)
1. The impact of journal advertisements on prescribers of cholinesterase inhibitors. Sauer J; Howard R Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061 [No Abstract] [Full Text] [Related]
2. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. Gasser US; Gasser T MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165 [No Abstract] [Full Text] [Related]
3. Featured CME topic: dementia. Medication update. Slagle MA South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174 [No Abstract] [Full Text] [Related]
4. [Mechanisms of action of Alzheimer medications]. Alhainen K Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001 [No Abstract] [Full Text] [Related]
5. A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease. Alisky JM J Alzheimers Dis; 2003 Dec; 5(6):477-8. PubMed ID: 14757938 [No Abstract] [Full Text] [Related]
6. Medications for the treatment of Alzheimer's disease. Lampley-Dallas VT J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383 [TBL] [Abstract][Full Text] [Related]
8. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161 [No Abstract] [Full Text] [Related]
9. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
10. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
11. New drugs for Alzheimer's disease in Japan. Takeda M; Tanaka T; Okochi M Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448 [No Abstract] [Full Text] [Related]
12. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available? Khang P; Weintraub N; Espinoza RT J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635 [No Abstract] [Full Text] [Related]
13. Use of cholinesterase inhibitors for treatment of Alzheimer disease. Hake AM Cleve Clin J Med; 2001 Jul; 68(7):608-9, 613-4, 616. PubMed ID: 11453078 [TBL] [Abstract][Full Text] [Related]
15. Switching from donepezil to galantamine: a double-blind study of two wash-out periods. Wilkinson DG; Howe I Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437 [No Abstract] [Full Text] [Related]
17. Advertisements for donepezil (Aricept) in the BMJ. Advertisement suggests an unrealistic improvement in mental status. Gray S BMJ; 1997 May; 314(7093):1555. PubMed ID: 9183222 [No Abstract] [Full Text] [Related]